Document is current
Any future updates will be listed below
-
Authors
Hirai, Toshinori
Tsuge, Kota
Ishiwata, Yasuyoshi
Izumi, Keita
Saito, Kazutaka
Nagata, Masashi
- License Information
-
More Information
Article History
Received: 18 July 2025
Accepted: 1 September 2025
First Online: 29 September 2025
Declarations
:
: The Institutional Review Board of Dokkyo Medical University Saitama Medical Center approved the study protocol (approval number: 24063). Written informed consent was obtained from patients treated with apalutamide.
: We did not obtain consent to participate because of a retrospective observational study.
: Keita Izumi and Kazutaka Saito received funding from Janssen Pharmaceutical K.K.
